LGR5 promotes survival in human colorectal adenoma cells and is upregulated by PGE2: Implications for targeting adenoma stem cells with nsaids

Carcinogenesis

Volumn 34, Issue 5, 2013, Pages 1150-1157

  Al Kharusi, Manal R A ^a   Smartt, Helena J M ^a   Greenhough, Alexander ^a   Collard, Tracey J ^a   Emery, Elizabeth D ^a   Williams, Ann C ^a   Paraskeva, Chris ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; G PROTEIN COUPLED RECEPTOR; LEUCINE RICH G PROTEIN COUPLED RECEPTOR 5; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2; UNCLASSIFIED DRUG;

ARTICLE; CANCER STEM CELL; CELL SURVIVAL; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; DRUG TARGETING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ADENOMA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BETA CATENIN; CARCINOMA; CELL LINE, TUMOR; CELL SURVIVAL; COLORECTAL NEOPLASMS; DINOPROSTONE; FEMALE; HUMANS; MIDDLE AGED; NEOPLASTIC STEM CELLS; RECEPTORS, G-PROTEIN-COUPLED; UP-REGULATION; WNT SIGNALING PATHWAY;

EID: 84875463275     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt020     Document Type: Article

References (44)

1. Fearon,E.R. et al. (1990) A genetic model for colorectal tumorigenesis. Cell, 61, 759-767.
2. Brown,J.R. et al. (2005) COX-2: a molecular target for colorectal cancer prevention. J. Clin. Oncol., 23, 2840-2855.
3. Kitamura,T. et al. (2002) Inhibitory effects of mofezolac, a cyclooxygenase-1 selective inhibitor, on intestinal carcinogenesis. Carcinogenesis, 23, 1463-1466.
4. Eberhart,C.E. et al. (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107, 1183-1188.
5. Elder,D.J. et al. (2002) Human colorectal adenomas demonstrate a sizedependent increase in epithelial cyclooxygenase-2 expression. J. Pathol., 198, 428-434.
6. Rigas,B. et al. (1993) Altered eicosanoid levels in human colon cancer. J. Lab. Clin. Med., 122, 518-523.
7. Greenhough,A. et al. (2009) The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis, 30, 377-386.
8. Waddell,W.R. et al. (1983) Sulindac for polyposis of the colon. J. Surg. Oncol., 24, 83-87.
9. Steinbach,G. et al. (2000) The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N. Engl. J. Med., 342, 1946-1952.
10. Menter,D.G. et al. (2010) Cyclooxygenase-2 and cancer treatment: understanding the risk should be worth the reward. Clin. Cancer Res., 16, 1384-1390.
11. Clevers,H. et al. (2012) Wnt/β-catenin signaling and disease. Cell, 149, 1192-1205.
12. Kinzler,K.W. et al. (1996) Lessons from hereditary colorectal cancer. Cell, 87, 159-170.
13. Korinek,V. et al. (1998) Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat. Genet., 19, 379-383.
14. Castellone,M.D. et al. (2005) Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science, 310, 1504-1510.
15. Shao,J. et al. (2005) Prostaglandin E2 stimulates the beta-catenin/T cell factor-dependent transcription in colon cancer. J. Biol. Chem., 280, 26565-26572.
16. Goessling,W. et al. (2009) Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration. Cell, 136, 1136-1147.
17. Barker,N. et al. (2007) Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature, 449, 1003-1007.
18. Barker,N. et al. (2007) Tracking down the stem cells of the intestine: strategies to identify adult stem cells. Gastroenterology, 133, 1755-1760.
19. de Lau,W. et al. (2011) Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. Nature, 476, 293-297.
20. Carmon,K.S. et al. (2011) R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/beta-catenin signaling. Proc. Natl Acad. Sci. USA, 108, 11452-11457.
21. Barker,N. et al. (2009) Crypt stem cells as the cells-of-origin of intestinal cancer. Nature, 457, 608-611.
22. Kemper,K. et al. (2012) Monoclonal antibodies against Lgr5 identify human colorectal cancer stem cells. Stem Cells, 30, 2378-2386.
23. Schepers,A.G. et al. (2012) Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science, 337, 730-735.
24. Jung,P. et al. (2011) Isolation and in vitro expansion of human colonic stem cells. Nat. Med., 17, 1225-1227.
25. Ziskin,J.L., et al. (2012) In situ validation of an intestinal stem cell signature in colorectal cancer. Gut online., doi:10.1136/gutjnl-2011-301195 [Epub ahead of print]
26. Paraskeva,C. et al. (1984) The isolation and characterization of colorectal epithelial cell lines at different stages in malignant transformation from familial polyposis coli patients. Int. J. Cancer, 34, 49-56.
27. Paraskeva,C. et al. (1988) Immortalization of a human colorectal adenoma cell line by continuous in vitro passage: possible involvement of chromosome 1 in tumour progression. Int. J. Cancer, 41, 908-912.
28. Williams,A.C. et al. (1990) Neoplastic transformation of a human colonic epithelial cell line: in vitro evidence for the adenoma to carcinoma sequence. Cancer Res., 50, 4724-4730.
29. Chell,S.D. et al. (2006) Increased EP4 receptor expression in colorectal cancer progression promotes cell growth and anchorage independence. Cancer Res., 66, 3106-3113.
30. Kirkland,S.C. (1985) Dome formation by a human colonic adenocarcinoma cell line (HCA-7). Cancer Res., 45, 3790-3795.
31. Moore,A.E. et al. (2009) HGF/Met signalling promotes PGE(2) biogenesis via regulation of COX-2 and 15-PGDH expression in colorectal cancer cells. Carcinogenesis, 30, 1796-1804.
32. Greenhough,A. et al. (2010) The proapoptotic BH3-only protein Bim is downregulated in a subset of colorectal cancers and is repressed by antiapoptotic COX-2/PGE(2) signalling in colorectal adenoma cells. Oncogene, 29, 3398-3410.
33. Kaidi,A. et al. (2007) Interaction between beta-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nat. Cell Biol., 9, 210-217.
34. de Sousa,E.M.F., et al. (2011) Methylation of cancer-stem-cell-associated Wnt target genes predicts poor prognosis in colorectal cancer patients. Cell Stem Cell, 9, 476-485.
35. Becker,L. et al. (2008) Immunostaining of Lgr5, an intestinal stem cell marker, in normal and premalignant human gastrointestinal tissue. Scientific World Journal., 8, 1168-1176.
36. Takeda,K. et al. (2011) Expression of LGR5, an intestinal stem cell marker, during each stage of colorectal tumorigenesis. Anticancer Res., 31, 263-270.
37. Hsu,S.Y. et al. (1998) Characterization of two LGR genes homologous to gonadotropin and thyrotropin receptors with extracellular leucinerich repeats and a G protein-coupled, seven-transmembrane region. Mol. Endocrinol., 12, 1830-1845.
38. Segditsas,S. et al. (2008) Putative direct and indirect Wnt targets identified through consistent gene expression changes in APC-mutant intestinal adenomas from humans and mice. Hum. Mol. Genet., 17, 3864-3875.
39. van de Wetering,M., et al. (2002) The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell, 111, 241-250.
40. Shackleton,M. et al. (2009) Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell, 138, 822-829.
41. Clevers,H. (2011) The cancer stem cell: premises, promises and challenges. Nat. Med., 17, 313-319.
42. Smartt,H.J. et al. (2012) β-Catenin represses expression of the tumour suppressor 15-prostaglandin dehydrogenase in the normal intestinal epithelium and colorectal tumour cells. Gut, 61, 1306-1314.
43. Pierzchalska,M. et al. (2012) Prostaglandin E2 supports growth of chicken embryo intestinal organoids in Matrigel matrix. BioTechniques, 52, 307-315.
44. Li,H.J. et al. (2012) Cancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signaling. Cancer Discov., 2, 840-855.